Page last updated: 2024-08-17

lactose and celecoxib

lactose has been researched along with celecoxib in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (42.86)29.6817
2010's4 (57.14)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Ekins, S; Williams, AJ; Xu, JJ1
Araman, A; Değim, T; Gönüllü, U; Uner, M; Yener, G1
Chandran, S; Ravi, P; Saha, RN1
El Ghazouani, F; Homar, M; Kerc, J; Kristl, J; Maincent, P; Ubrich, N1
Paul, S; Sun, CC1
Boulas, P; Dun, J; Lin, Y; Osei-Yeboah, F; Sun, CC1

Other Studies

7 other study(ies) available for lactose and celecoxib

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
Effect of vehicles and penetration enhancers on the in vitro percutaneous absorption of celecoxib through human skin.
    Die Pharmazie, 2003, Volume: 58, Issue:5

    Topics: Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Emulsions; Gels; Humans; In Vitro Techniques; Isoenzymes; Lactose; Membrane Proteins; Methylcellulose; Ointments; Oxazines; Pharmaceutical Vehicles; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Skin Absorption; Solubility; Spectrophotometry, Ultraviolet; Sulfonamides

2003
Development and in vitro evaluation of oral controlled release formulations of celecoxib using optimization techniques.
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2006, Volume: 126, Issue:7

    Topics: Celecoxib; Cellulose; Chemistry, Pharmaceutical; Delayed-Action Preparations; Lactose; Methylcellulose; Pyrazoles; Solubility; Sulfonamides; Tablets; Technology, Pharmaceutical

2006
Influence of polymers on the bioavailability of microencapsulated celecoxib.
    Journal of microencapsulation, 2007, Volume: 24, Issue:7

    Topics: Administration, Oral; Animals; Biological Availability; Celecoxib; Cellulose; Chemistry, Pharmaceutical; Cyclooxygenase Inhibitors; Drug Compounding; Drug Delivery Systems; Lactose; Male; Particle Size; Polymers; Pyrazoles; Rabbits; Sulfonamides

2007
The suitability of common compressibility equations for characterizing plasticity of diverse powders.
    International journal of pharmaceutics, 2017, Oct-30, Volume: 532, Issue:1

    Topics: Algorithms; Calcium Phosphates; Celecoxib; Cellulose; Compressive Strength; Excipients; Hardness; Ibuprofen; Lactose; Mannitol; Powders; Stearic Acids

2017
A systematic evaluation of dual functionality of sodium lauryl sulfate as a tablet lubricant and wetting enhancer.
    International journal of pharmaceutics, 2018, Dec-01, Volume: 552, Issue:1-2

    Topics: Celecoxib; Cellulose; Lactose; Lubricants; Sodium Dodecyl Sulfate; Stearic Acids; Surface-Active Agents; Tablets; Wettability

2018